KEQU
KEQU
NASDAQ · Health Care

Kewaunee Scientific Cp

$34.16
+0.25 (+0.74%)
As of Oct 3, 2:29 AM ET ·
Financial Highlights (FY 2026)
Revenue
275.07M
Net Income
9.38M
Gross Margin
28.5%
Profit Margin
3.4%
Rev Growth
+8.7%
D/E Ratio
0.63
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 28.5% 28.5% 50.5% 50.5%
Operating Margin 5.9% 5.3% 10.7% 9.9%
Profit Margin 3.4% 3.2% 9.0% 9.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 275.07M 253.04M 59.81M 50.24M
Gross Profit 78.45M 72.17M 30.19M 25.36M
Operating Income 16.31M 13.50M 6.40M 4.98M
Net Income 9.38M 7.77M 5.37M 4.75M
Gross Margin 28.5% 28.5% 50.5% 50.5%
Operating Margin 5.9% 5.3% 10.7% 9.9%
Profit Margin 3.4% 3.2% 9.0% 9.5%
Rev Growth +8.7% +8.7% +13.1% -4.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 19.13M 19.13M 32.14M 29.26M
Total Equity 30.57M 30.57M 76.20M 84.12M
D/E Ratio 0.63 0.63 0.42 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 22.43M 19.60M 8.28M 7.47M
Free Cash Flow — — 3.50M 3.36M